RxDoctor Payments Data

Udo Hoffmann

Diagnostic Radiology · Boston, MANPI 1538133608

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Cleerly, Inc. accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest.

$2,635in general payments, 2019–2025

Across 3 payments — averaging $878.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cleerly, Inc.$3K
  • Astrazeneca UK Limited$12
$1,674,389in research payments, 2019–2025

Across 5 payments — averaging $334,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$1.6M
  • Heartflow, Inc.$90K

What the payments were for

  • Food & beverage$2,635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cleerly, Inc.2$2,623
Astrazeneca UK Limited1$12

How this compares

$2,635 in reported general payments places this provider in the 85th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →